Concepedia

Matthew R. Griffiths

MR

Statistics

Publications

15

Citations

1.7K

H-Index

13

Active since

1997

Affiliations

Vertex Pharmaceuticals (United Kingdom)(Current)

University of Bristol

Royal Brisbane and Women's Hospital

Queensland University of Technology

St Vincent's Hospital Melbourne

Matthew R. Griffiths is an author at Vertex Pharmaceuticals (United Kingdom) specializing in life sciences, molecular biology, and medicine.

Publications per year

1997–2024

15

Publications

15

Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR

Philip M. Reaper, Matthew R. Griffiths, Joanna Long et al. · Nature Chemical Biology · 2011 · 639 citations

, , +14

Colorectal Cancer: Texture Analysis of Portal Phase Hepatic CT Images as a Potential Marker of Survival

Kenneth A. Miles, Balaji Ganeshan, Matthew R. Griffiths et al. · Radiology · 2009 · 257 citations · Full text

, , +17

Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical Cancer

Paul J. Adam, Robert S. Boyd, Kerry Tyson et al. · Journal of Biological Chemistry · 2003 · 209 citations · Full text

, , +17

Standardized Perfusion Value: Universal CT Contrast Enhancement Scale that Correlates with FDG PET in Lung Nodules

Kenneth A. Miles, Matthew R. Griffiths, Melanie A. Fuentes · Radiology · 2001 · 100 citations

, , +17

Two Naturally Occurring Insulin Receptor Tyrosine Kinase Domain Mutants Provide Evidence That Phosphoinositide 3-Kinase Activation Alone Is Not Sufficient for the Mediation of Insulin's Metabolic and Mitogenic Effects

Anna Krook, Jonathan P. Whitehead, Stephen P. Dobson et al. · Journal of Biological Chemistry · 1997 · 90 citations · Full text

, , +17

1–5 of 15